Andrey Ziyatdinov, Joelle Mbatchou, Anthony Marcketta, Joshua Backman, Sheila Gaynor, Yuxin Zou, Tyler Joseph, Benjamin Geraghty, Joseph Herman, Kyoko Watanabe, Arkopravo Ghosh, Jack Kosmicki, Adam Locke, Timothy Thornton, Hyun Min Kang, Manuel Ferreira, Aris Baras, Goncalo Abecasis, Jonathan Marchini
{"title":"Joint testing of rare variant burden scores using non-negative least squares.","authors":"Andrey Ziyatdinov, Joelle Mbatchou, Anthony Marcketta, Joshua Backman, Sheila Gaynor, Yuxin Zou, Tyler Joseph, Benjamin Geraghty, Joseph Herman, Kyoko Watanabe, Arkopravo Ghosh, Jack Kosmicki, Adam Locke, Timothy Thornton, Hyun Min Kang, Manuel Ferreira, Aris Baras, Goncalo Abecasis, Jonathan Marchini","doi":"10.1016/j.ajhg.2024.08.021","DOIUrl":null,"url":null,"abstract":"<p><p>Gene-based burden tests are a popular and powerful approach for analysis of exome-wide association studies. These approaches combine sets of variants within a gene into a single burden score that is then tested for association. Typically, a range of burden scores are calculated and tested across a range of annotation classes and frequency bins. Correlation between these tests can complicate the multiple testing correction and hamper interpretation of the results. We introduce a method called the sparse burden association test (SBAT) that tests the joint set of burden scores under the assumption that causal burden scores act in the same effect direction. The method simultaneously assesses the significance of the model fit and selects the set of burden scores that best explain the association at the same time. Using simulated data, we show that the method is well calibrated and highlight scenarios where the test outperforms existing gene-based tests. We apply the method to 73 quantitative traits from the UK Biobank, showing that SBAT is a valuable additional gene-based test when combined with other existing approaches. This test is implemented in the REGENIE software.</p>","PeriodicalId":7659,"journal":{"name":"American journal of human genetics","volume":"111 10","pages":"2139-2149"},"PeriodicalIF":8.1000,"publicationDate":"2024-10-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11480795/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American journal of human genetics","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.1016/j.ajhg.2024.08.021","RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"GENETICS & HEREDITY","Score":null,"Total":0}
引用次数: 0
Abstract
Gene-based burden tests are a popular and powerful approach for analysis of exome-wide association studies. These approaches combine sets of variants within a gene into a single burden score that is then tested for association. Typically, a range of burden scores are calculated and tested across a range of annotation classes and frequency bins. Correlation between these tests can complicate the multiple testing correction and hamper interpretation of the results. We introduce a method called the sparse burden association test (SBAT) that tests the joint set of burden scores under the assumption that causal burden scores act in the same effect direction. The method simultaneously assesses the significance of the model fit and selects the set of burden scores that best explain the association at the same time. Using simulated data, we show that the method is well calibrated and highlight scenarios where the test outperforms existing gene-based tests. We apply the method to 73 quantitative traits from the UK Biobank, showing that SBAT is a valuable additional gene-based test when combined with other existing approaches. This test is implemented in the REGENIE software.
期刊介绍:
The American Journal of Human Genetics (AJHG) is a monthly journal published by Cell Press, chosen by The American Society of Human Genetics (ASHG) as its premier publication starting from January 2008. AJHG represents Cell Press's first society-owned journal, and both ASHG and Cell Press anticipate significant synergies between AJHG content and that of other Cell Press titles.